MENU
PVLA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Palvella Therapeutics (PVLA) Ownership - Who owns Palvella Therapeutics?

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.7B
P/E Ratio
14.22
Total Cash
261.85M
Projected Growth
N/A
Total Debt
584K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
18.26
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
PVLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details